Loading...
OTCM
CUTRQ
Market cap167kUSD
May 01, Last price  
0.01USD
Name

Cutera Inc

Chart & Performance

D1W1MN
No data to show
P/E
P/S
0.00
EPS
Div Yield, %
Shrs. gr., 5y
7.62%
Rev. gr., 5y
5.47%
Revenues
212m
-15.86%
52,641,00075,620,000100,692,000101,726,00083,379,00053,682,00053,274,00060,290,00077,277,00074,594,00078,138,00094,761,000118,056,000151,493,000162,720,000181,712,000147,683,000231,270,000252,399,000212,369,000
Net income
-163m
L+97.76%
3,760,00013,801,0002,123,00010,504,000-2,869,000-17,679,000-10,518,000-10,061,000-6,548,000-4,747,000-10,612,000-4,440,0002,577,00029,993,000-30,770,000-12,348,000-23,877,0002,062,000-82,340,000-162,833,000
CFO
-138m
L+105.79%
9,244,00020,388,00012,466,00016,890,0004,340,00041,000-8,059,000-5,168,000-2,300,0003,513,000-4,286,000-1,359,0001,992,00014,287,000307,000-2,217,000-16,956,0001,235,000-66,995,000-137,870,000
Earnings
Aug 06, 2025

Profile

Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.
IPO date
Mar 31, 2004
Employees
540
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
212,369
-15.86%
252,399
9.14%
Cost of revenue
368,599
290,589
Unusual Expense (Income)
NOPBT
(156,230)
(38,190)
NOPBT Margin
Operating Taxes
1,534
1,638
Tax Rate
NOPAT
(157,764)
(39,828)
Net income
(162,833)
97.76%
(82,340)
-4,093.21%
Dividends
Dividend yield
Proceeds from repurchase of equity
(1,974)
(53,957)
BB yield
2.82%
6.51%
Debt
Debt current
3,266
2,810
Long-term debt
439,974
441,973
Deferred revenue
1,494
1,657
Other long-term liabilities
234
862
Net debt
299,628
127,469
Cash flow
Cash from operating activities
(137,870)
(66,995)
CAPEX
(33,010)
(22,698)
Cash from investing activities
137,426
(194,182)
Cash from financing activities
(2,568)
242,937
FCF
(169,115)
(91,562)
Balance
Cash
143,612
317,314
Long term investments
Excess cash
132,994
304,694
Stockholders' equity
(303,326)
(140,587)
Invested Capital
565,136
549,480
ROIC
ROCE
EV
Common stock shares outstanding
19,885
18,747
Price
3.53
-92.03%
44.22
7.02%
Market cap
70,095
-91.54%
828,992
9.26%
EV
369,723
956,461
EBITDA
(147,655)
(35,569)
EV/EBITDA
Interest
14,016
5,658
Interest/NOPBT